MyMD Pharmaceuticals (MYMD)
NASDAQ:MYMD
Holding MYMD?
Track your performance easily

MyMD Pharmaceuticals (MYMD) Stock News & Sentiment

533 Followers
MyMD Pharmaceuticals Rebrands as TNF Pharmaceuticals
Premium
Company Announcements
MyMD Pharmaceuticals Rebrands as TNF Pharmaceuticals
4M ago
MyMD Pharmaceuticals Executes Strategic Financial and Leadership Restructuring
Premium
Company Announcements
MyMD Pharmaceuticals Executes Strategic Financial and Leadership Restructuring
5M ago
MyMD Pharmaceuticals Enhances Governance and Financing Structure
Premium
Company Announcements
MyMD Pharmaceuticals Enhances Governance and Financing Structure
7M ago

News Score - Last 7 Days

Neutral
MYMD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MYMD’s Media Buzz Sentiment?
1 articles about MYMD were published this week. In an average week, 1 articles are published.
    What is MYMD’s weekly average amount of articles?
    In an average week, 1 articles about MYMD are published.
      What is MYMD’s News Sentiment?
      50% of articles about MYMD were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        ITGRInteger Holdings
        OMIOwens & Minor
        OBIOOrchestra BioMed Holdings
        BHCBausch Health Companies
        BSXBoston Scientific
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis